Importantly, the glucose-platinum conjugate substituted in the C2-position, which showed the greatest GLUT1 specific internalization and the highest cancer targeting ability, demonstrated anti-tumor efficacy and selective uptake in tumors with no observable toxicity in a syngeneic breast cancer mouse model overexpressing GLUT1 [283]. The gene discussed is SLC2A1; the disease is neoplasm.